Axitinib Axitinib
≥99%
- Product Code: 74163
CAS:
319460-85-0
| Molecular Weight: | 386.47 g./mol | Molecular Formula: | C₂₂H₁₈N₄OS |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD09837898 | |
| Melting Point: | 213-215°C | Boiling Point: | 668.9°C |
| Density: | 1.35 g/mL | Storage Condition: | room temperature, dry |
Product Description:
Axitinib is primarily used in the treatment of advanced renal cell carcinoma (RCC), a type of kidney cancer. It functions as a tyrosine kinase inhibitor, targeting vascular endothelial growth factor receptors (VEGFRs) to inhibit tumor growth and angiogenesis. This makes it effective in slowing the progression of cancer by cutting off the blood supply to tumors. Axitinib is often prescribed when previous treatments have failed, providing an alternative option for patients with resistant or advanced disease. It is administered orally, allowing for convenient at-home use, and is typically taken in combination with other therapies to enhance its efficacy. Regular monitoring is required to manage potential side effects, such as hypertension and fatigue.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | White to off-white solid |
| PURITY | 98.5 100% |
| Infrared spectrum | Conforms to Structure |
| CARBON BY ELEMENTAL ANALYSIS | 67.1 % 68.9 % |
| NITROGEN BY ELEMENTAL ANALYSIS | 13.8 % 14.9 % |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.050 | 10-20 days | ฿1,200.00 |
+
-
|
| 0.250 | 10-20 days | ฿4,650.00 |
+
-
|
| 1.000 | 10-20 days | ฿8,500.00 |
+
-
|
Axitinib Axitinib
Axitinib is primarily used in the treatment of advanced renal cell carcinoma (RCC), a type of kidney cancer. It functions as a tyrosine kinase inhibitor, targeting vascular endothelial growth factor receptors (VEGFRs) to inhibit tumor growth and angiogenesis. This makes it effective in slowing the progression of cancer by cutting off the blood supply to tumors. Axitinib is often prescribed when previous treatments have failed, providing an alternative option for patients with resistant or advanced disease. It is administered orally, allowing for convenient at-home use, and is typically taken in combination with other therapies to enhance its efficacy. Regular monitoring is required to manage potential side effects, such as hypertension and fatigue.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :